Lung transplant surgery

For patients with end-stage pulmonary disease unresponsive to standard therapies, lung transplant surgery stands as a life-saving intervention that offers not only prolonged survival but also improved quality of life. The pathway to transplantation involves rigorous patient selection, addressing comorbidities, psychosocial factors, and infection risk to ensure the best possible outcomes. Over recent decades, advances in organ preservation and surgical techniques have substantially expanded the donor pool and improved post-operative results. Ex vivo lung perfusion is a landmark innovation, enabling the reconditioning of marginal donor organs and significantly increasing availability for transplantation. Post-surgical care is equally critical, involving long-term immunosuppression, infection prophylaxis, and surveillance for acute and chronic rejection, particularly bronchiolitis obliterans syndrome. Rehabilitation programs that incorporate physiotherapy, nutritional support, and psychological counseling play a vital role in patient recovery and reintegration into daily life. Beyond current practice, future developments include the potential of xenotransplantation, bioengineered lungs, and regenerative medicine approaches, which may help address the persistent shortage of donor organs. The evolving field of lung transplant surgery exemplifies multidisciplinary collaboration between surgeons, pulmonologists, immunologists, and allied health professionals, all working toward the goal of not only extending life but restoring meaningful functionality for individuals who otherwise face limited therapeutic options.